Miles Landis, MD

Overview

Dr. Landis has been practicing pediatrics in Central Florida since 1988. In addition to providing primary health care services for children of all ages, he serves as an investigator for clinical trials aimed at improving treatments for a variety of disorders diagnosed in childhood - including autism, asthma, and immunization preventable disease. An honors graduate of Rensselaer Polytechnic Institute in New York, he earned his medical degree at the University of Buffalo and continued at the Children's Hospital of Buffalo for his pediatric internship and residency programs. He is a Fellow of the American Academy of Pediatrics.

Associated Clinical Trials

NCT02649959

An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism

The purpose of this research study is to test the safety, tolerability, and effectiveness of the pancreatic digestive enzyme, CM-AT, when used to treat Autistic Disorder. Enzymes are proteins naturally found in the body and can ...

NCT02410902

A Double Blind Randomized Placebo Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin

This is a Phase III multi-center, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of CM-AT in pediatric patients with autism at all levels of fecal chymotrypsin.

NCT03537508

Immunogenicity and Safety Study of an INvestigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers

The main purpose of this study is to find out if the MenACYW conjugate vaccine is safe and can protect young children against meningococcal disease when it is given at the same time with the childhood vaccines recommended in th ...

NCT04507204

Real-World Evidence of Duration of Effect of Adhansia XR for Treatment of ADHD (RE-DAX)

This study is currently enrolling.

The main purpose of this study is to test if Adhansia XR is effective in treating adolescent and adult patients diagnosed with ADHD. In addition, Adhansia XR's effectiveness in treating ADHD will be compared with OROS MPH ...

Miles Landis, MD

Overview

Education & Training

Education

Residency

Board Certifications

Associated Clinical Trials

An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism

A Double Blind Randomized Placebo Controlled Study of CM-AT for the Treatment of Autism in Children With All Levels of Fecal Chymotrypsin

Immunogenicity and Safety Study of an INvestigational Quadrivalent Meningococcal Conjugate Vaccine when Administered Concomitantly with Routine Pediatric Vaccines in Healthy Infants and Toddlers

Real-World Evidence of Duration of Effect of Adhansia XR for Treatment of ADHD (RE-DAX)

Explore

Institutes